Sign in

NCT07206654Completed

Prevalence and Determinants of Shoulder Girdle Musculoskeletal Complaints in Geriatric Patients With Diminished Vision

A Case-Control Study on the Presence, Causes, and Frequencies of Shoulder Girdle Musculoskeletal Complaints in Geriatrics With Diminished Vision

Source: ClinicalTrials.gov · Last updated 3 Oct 2025

Brief summary (registry, in English)

This case-control study aims to investigate the prevalence and determinants of shoulder girdle musculoskeletal complaints (pain, spasm, stiffness, range of motion impairments) in geriatric patients (aged 60+) with diminished vision (visual acuity \<6/60) due to Age-related Macular Degeneration (AMD), compared to a control group of age-matched elderly individuals with normal vision. The study will also assess the impact of these complaints on functional ability (Activities of Daily Living - ADL, Instrumental Activities of Daily Living - IADL) and quality of life using standardized questionnaires.

Status (registry)
Completed
Study type
Observational
Enrollment
100 (actual)
First submitted
26 Sept 2025
Start date
1 Sept 2023
Primary completion date
28 Apr 2025
Lead sponsor
Beni-Suef University
NCT number
NCT07206654

What you commit to

  • Study type: Observational
  • Participants enrolled: 100
  • From 1 Sept 2023 to the primary completion date, 28 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Musculoskeletal complaints due to Parkinsonism.
    • Musculoskeletal complaints due to Osteoarthritis (OA) or Multiple Sclerosis (MS).
    • Inability to provide informed consent.

Who the study is looking for

  • Patients aged 60 years or older.
    • For Case Group: Documented diagnosis of Age-Related Macular Degeneration (AMD) with visual impairment (visual acuity \< 6/60).
    • For Control Group: Normal vision, free from AMD as diagnosed by fundus examination and Snellen test.

Age in the registry: 60 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Beni Suef University
Coordinator of this site? Confirm its status
Banī SuwayfEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.